Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,47 USD | +1,05% | -1,59% | -22,18% |
Omzet 2024 * | 15,35 mln. 19,17 mln. 17,93 mln. | Omzet 2025 * | 103 mln. 129 mln. 121 mln. | Marktkapitalisatie | 992 mln. 1,24 mld. 1,16 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -83 mln. -104 mln. -96,94 mln. | Nettowinst (verlies) 2025 * | -38 mln. -47,47 mln. -44,38 mln. | EV/omzet 2024 * | 52,7 x |
Nettoliquiditeiten 2024 * | 184 mln. 230 mln. 215 mln. | Nettoliquiditeiten 2025 * | 146 mln. 183 mln. 171 mln. | EV/omzet 2025 * | 8,19 x |
K/w-verhouding 2024 * |
-23,9
x | K/w-verhouding 2025 * |
-80,6
x | Werknemers | 79 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,42% |
Recentste transcriptie over Verona Pharma plc
1 dag | +1,05% | ||
1 week | -1,59% | ||
Lopende maand | -3,85% | ||
1 maand | -6,24% | ||
3 maanden | -18,88% | ||
6 maanden | +16,84% | ||
Lopend jaar | -22,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 59 | 01-02-20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01-03-20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17-06-16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12-09-16 |
David Ebsworth
CHM | Chairman | 69 | 01-12-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.09% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 15,31 | +0,46% | 499 479 |
24-04-24 | 15,24 | -2,25% | 316 407 |
23-04-24 | 15,59 | -0,83% | 359 330 |
22-04-24 | 15,72 | 0,00% | 459 032 |
19-04-24 | 15,72 | -2,36% | 718 556 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-22,18% | 1,24 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |